A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19
| Autor: | Seethamraju, Harish, Yang, Otto O., Loftus, Richard, Ogbuagu, Onyema, Sammartino, Daniel, Mansour, Ali, Sacha, Jonah B., Ojha, Sohita, Hansen, Scott G., Arman, Arvin Cyrus, Lalezari, Jacob P. |
|---|---|
| Zdroj: | In Clinical Therapeutics November 2024 46(11):891-899 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect